Close Menu

Sciex

Caprion Proteome is leading a four-year, C$21 million (US$20.5 million) public-private partnership focused on development and implementation of clinical biomarkers and personalized medicine strategies for oncology.

After years of technical setbacks and challenges, mass spec-based clinical proteomics is "ready for prime time," a Thermo Fisher Scientific researcher told ProteoMonitor this week.

AB Sciex this week introduced its new AB Sciex API 3200MD and 3200MD QTRAP mass spectrometers, both intended as in vitro diagnostic devices and registered with the US Food and Drug Administration as Class I exempt devices.

AB Sciex said this week that it has signed a multi-year collaboration agreement with the Institute of Systems Biology to develop methods related to its SWATH mass spectrometry technology.

NEW YORK (GenomeWeb News) – The Institute for Systems Biology and AB Sciex today announced a partnership aimed at the development of a new mass spectrometry workflow.

A team led by researchers at the Swiss Federal Institute of Technology Zurich and the Institute for Systems Biology has published a pair of mass spec reference spectral libraries covering nearly the entire yeast proteome.

Executives from several major mass spec vendors presented this week at the JP Morgan Healthcare Conference in San Francisco, offering comments on their company's recent performances and glimpses into their plans moving into 2013.

You might say 2012 was the year that proteomics shed its Rodney Dangerfield routine and began to get some respect.

Researchers from the University of Wisconsin-Madison have characterized the mitochondrial acetylome, finding significant changes in protein acetylation in response to calorie restriction and activity of the protein deacetylase SIRT3.

Researchers at the Swiss Federal Institute of Technology Zurich have performed a targeted proteomic analysis of pre-ribosomal complexes using a combination of shotgun and selected-reaction monitoring mass spectrometry.

Pages

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.

Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.